HSBC Innovation Banking CEO: UK's Next Innovation Phase Driven by Deep Tech
UK Innovation's Next Phase: Deep Tech, Life Sciences Lead

HSBC Innovation Banking CEO: The Next Phase of UK Innovation Will Be Won Quietly

By Emily Turner

The United Kingdom's innovation economy has surged to a staggering value of $1.3 trillion, with artificial intelligence capturing significant attention and investment. However, the true drivers of long-term economic impact lie beneath the surface, in sectors that operate with less fanfare but greater durability.

Deep Tech, Life Sciences, and Infrastructure Lead the Charge

The forthcoming phase of UK innovation will be propelled by deep tech, life sciences, and infrastructure-heavy businesses. These enterprises require extended timelines for development and monetization, demanding scientific expertise, specialized talent, and patient capital. In return, they generate resilient revenue streams, protectable intellectual property, and global relevance, forming the bedrock of sustained economic influence.

Recent data from an Innovation Update with Dealroom.co reveals that fintech constitutes 32 percent of the UK's total innovation value, while deep tech accounts for 20 percent and life sciences and healthcare make up 13 percent. This ecosystem is deeply rooted in scientific advancements and complex platforms integrated into financial services, healthcare, energy networks, and advanced computing.

Megarounds Highlight Infrastructure Investments

In 2025, the UK witnessed 36 megarounds of $100 million or more, marking the strongest performance since the peak of 2021–22. While consumer AI dominated public discourse, capital allocation told a broader story of long-term conviction. Notable raises included Quantinuum's $600 million for quantum computing, Kraken's $1 billion for scaling its energy and utilities operating system, Nscale's $1.1 billion for expanding AI infrastructure, and Isomorphic Labs' $600 million to accelerate AI-driven drug discovery.

The common denominator among these investments is infrastructure. These companies are constructing foundational platforms that quietly transform energy systems, drug discovery processes, and advanced computing deployments, thereby modernizing the core architecture of the economy and enhancing productivity across sectors.

Spinouts Demonstrate UK's Leadership in Deep Tech

The UK leads Europe in deep tech and life sciences spinout value creation, with half of Europe's top 10 universities for spinout value located here. In 2025, spinouts raised $2.5 billion, including ventures like OrganOx, PolyAI, and Nu Quantum. These companies are slower to develop due to their basis in breakthrough science but are more difficult to displace, protected by robust intellectual property and years of research, anchoring innovation ecosystems for decades.

Future Value Creation and Ecosystem Maturity

Private companies still represent approximately half of the UK's total tech value, with the remainder divided between public and acquired firms. This indicates that significant value creation through exits, listings, or global expansion is yet to come, particularly in deep tech and life sciences, where longer scaling cycles precede substantial returns.

With 200 unicorns and 239 "thoroughbreds"—companies generating over $100 million in revenue—the UK has developed considerable depth. This market no longer relies on a few standout successes but possesses the scale and institutional maturity necessary to compound value over the next decade, recycling capital, talent, and expertise back into the system.

In a global AI cycle characterized by hype and speed, the UK's competitive advantage lies in patience, scientific depth, and ecosystem maturity. The next generation of winners may not dominate headlines, but they will strengthen economic foundations, create skilled jobs, and yield long-term returns. With continued support and capital, this next phase of UK innovation will be won quietly, yet its impact will be profound.